TYPE: Prescription

BRAND: Ezetimibe Rowa

ACTIVE INGREDIENT: Ezetimibe

STRENGTH, PACK SIZE & GMS CODES:

Ezetimibe Rowa 10mg x 28 – 36888

 

INDICATION:

Primary Hypercholesterolaemia:

  • Co-administered with an HMG-CoA reductase inhibitor (statin) as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia who are not appropriately controlled with a statin alone.
  • Monotherapy as adjunctive therapy to diet for use in patients with primary (heterozygous familial and nonfamilial) hypercholesterolaemia in whom a statin is considered inappropriate or is not tolerated.

Prevention of Cardiovascular Events:

  • To reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) when added to ongoing statin therapy or initiated concomitantly with a statin.

Homozygous Familial Hypercholesterolaemia (HoFH):

  • Co-administered with a statin as adjunctive therapy to diet for use in patients with HoFH.
  • Patients may also receive adjunctive treatments (e.g., LDL apheresis).

 

Download Ezetimibe Rowa 10mg SPC here

Download Ezetimibe Rowa 10mg PIL here